PetMed Express, Inc.
PETS
$2.46
$0.031.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 182.67M | 193.97M | 207.65M | 222.68M | 235.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 182.67M | 193.97M | 207.65M | 222.68M | 235.75M |
| Cost of Revenue | 127.45M | 132.08M | 139.40M | 149.79M | 157.51M |
| Gross Profit | 55.22M | 61.90M | 68.25M | 72.89M | 78.24M |
| SG&A Expenses | 84.54M | 81.81M | 80.77M | 74.65M | 69.44M |
| Depreciation & Amortization | 9.03M | 8.22M | 7.60M | 7.04M | 6.86M |
| Other Operating Expenses | -1.18M | -1.18M | -1.18M | -1.18M | -1.09M |
| Total Operating Expenses | 219.85M | 220.93M | 226.59M | 230.31M | 232.72M |
| Operating Income | -37.18M | -26.96M | -18.94M | -7.63M | 3.03M |
| Income Before Tax | -59.18M | -48.88M | -39.44M | -587.00K | 1.92M |
| Income Tax Expenses | 5.69M | 6.15M | 4.74M | 5.68M | 1.56M |
| Earnings from Continuing Operations | -64.87 | -55.02 | -44.18 | -6.27 | 0.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.87M | -55.02M | -44.18M | -6.27M | 357.00K |
| EBIT | -37.18M | -26.96M | -18.94M | -7.63M | 3.03M |
| EBITDA | -28.14M | -18.74M | -11.34M | -589.00K | 8.89M |
| EPS Basic | -3.12 | -2.65 | -2.13 | -0.30 | 0.02 |
| Normalized Basic EPS | -1.12 | -0.81 | -0.55 | -0.20 | 0.13 |
| EPS Diluted | -3.13 | -2.66 | -2.14 | -0.31 | 0.01 |
| Normalized Diluted EPS | -1.12 | -0.81 | -0.55 | -0.21 | 0.13 |
| Average Basic Shares Outstanding | 83.29M | 82.92M | 82.63M | 82.38M | 82.19M |
| Average Diluted Shares Outstanding | 83.29M | 82.92M | 82.97M | 83.15M | 82.96M |
| Dividend Per Share | -- | -- | -- | -- | 0.00 |
| Payout Ratio | -0.04% | -0.05% | -0.18% | -2.89% | 54.34% |